Patents for A61K 49 - Preparations for testing in vivo (35,376)
07/2013
07/31/2013EP2618848A1 Vascular imaging agents
07/31/2013CN203089533U Operation system using laser heat for treating fundus diseases
07/31/2013CN103228297A Aptamer labeled with F-19 nucleus for targeted molecular imaging by MRI
07/31/2013CN103224787A Rare earth-doped alkaline earth metal fluoride nano material, and preparation method and application thereof
07/31/2013CN103224495A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
07/31/2013CN103223179A Novel ultrasonic coupling agent
07/31/2013CN103223178A Preparation method of folic acid modified multifunctional targeted contrast agent magnetic iron oxide/gold nanoparticles
07/31/2013CN102614535B Medical contrast agent and manufacuture method for microbubbles containing fluorescent gold nanoclusters
07/31/2013CN101875508B Preparation method of Fe3O4 nano-magnetic powder lymphatic tracer and application thereof
07/30/2013USRE44399 One dose vaccination with Mycoplasma hyopneumoniae
07/30/2013US8497070 Angiogenin mutations and amyotrophic lateral sclerosis or motor neuron disease
07/30/2013US8496927 CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereof
07/30/2013US8496912 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
07/30/2013US8496911 Tissue stabilization for heart failure
07/30/2013CA2518944C Inhibitors of extracellular hsp90
07/25/2013WO2013109963A1 Fluorescent compositions with enhanced fluorescence and methods based thereon
07/25/2013WO2013107415A1 Cell-targeted magnetic nano-material and biomedical uses thereof
07/25/2013US20130190605 Methods and compositions for objectively characterizing medical images
07/25/2013US20130189519 Drug and Imaging Agent Delivery Compositions and Methods
07/25/2013US20130189189 COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCs
07/25/2013US20130189187 Nano-scale contrast agents and methods of use
07/25/2013DE102004038134B4 Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung Multivalent chelators for modifying and organizing of target molecules, processes for their preparation and their use
07/24/2013EP2618145A1 Method for quantitative measurement of gastric acidity using 13c carbonate salt
07/24/2013EP2615968A1 Micro devices biomedical applications and uses of the same
07/24/2013CN1853730B Modified cytokines for use in cancer therapy
07/24/2013CN103221334A Iron oxide nanocapsules, method of manufacturing the same, and MRI contrast agent using the same
07/24/2013CN103221071A Modeling of pharmaceutical propagation and parameter generation for injection protocols
07/24/2013CN103215039A Multifunctional rare-earth doped silicon gadolinium oxide-base composite nanomaterial, as well as preparation method and application thereof
07/24/2013CN103215031A Iridium complexe-polyvinylpyrrolidone hypoxic probe, its preparation method and application
07/24/2013CN103213967A Magnetic water-soluble carbon nano tube as well as preparation method and application thereof
07/24/2013CN103212094A Oxygen-fluorine liposome microbubble and preparation method thereof
07/24/2013CN103212093A Magnetic nano-grade material with cell-targeting property, and biomedical application thereof
07/24/2013CN103212092A Multifunctional coordination copolymer nanometer material as well preparation method and application thereof
07/24/2013CN103212091A Preparation method of hepatocarcinoma target CT (Computed Tomography) contrast medium based on Au DENPs-LA (Dendrimer-entrapped Gold Nanoparticles-Lactobionic acid)
07/24/2013CN103212085A Molecules for targeting compounds to various selected organs or tissues
07/24/2013CN103212072A An antigen associated with lung cancers and lymphomas
07/24/2013CN103212070A Method for treating joint damage
07/24/2013CN103211821A Drugs and uses
07/24/2013CN103211767A Preparation method of multifunctional eccentric mesoporous silicon dioxide core-shell nano particles
07/24/2013CN103211762A Novel diagnosis and treatment integrated hybridization micelle and preparation method thereof
07/24/2013CN102727911B Diamino polyethylene glycol modified paramagnetic metal complex magnetic resonance imaging contrast agent
07/24/2013CN102380109B Magnetic resonance contrast agent constructed by amphipathic polysaccharide-wrapped super-paramagnetic nanoparticles and preparation method thereof
07/24/2013CN102120773B Dual specificity antibodies and methods of making and using
07/24/2013CN101942022B Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof
07/24/2013CN101928458B Preparation method of multifunctional nanometer composite particle constructed by modified polymine
07/24/2013CN101721716B Dendrimer CT targeted contrast agent of load nano-Au particles and preparation method thereof
07/23/2013US8492358 Agonists of toll-like receptor 3 and methods of their use
07/23/2013US8491871 Method for assessing risk of heart failure
07/23/2013US8491870 Method for detection and treatment of aneurysms
07/23/2013US8491630 Post-biopsy cavity treatment implants and methods
07/23/2013US8491482 Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging
07/23/2013CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins
07/18/2013WO2013106824A1 Epherin receptor targeting agents
07/18/2013WO2013106672A1 Methods and compositions for the treatment of neurodegenerative disease
07/18/2013WO2013104690A1 X-ray imaging contrast media with low iodine concentration and x-ray imaging process
07/18/2013WO2013104586A1 Methods for preventing, treating or diagnosing disorders
07/18/2013WO2013104132A1 Method for measuring diffusion parameters of tracer in living organ tissue space and extracellular space
07/18/2013US20130184444 Compact nanoparticles for biological applications
07/18/2013US20130183249 Stimulus Sensitive Magnetic Nanocomposite Using Pyrene Polymer, and Contrast Medium Composition Containing the Nanocomposite
07/18/2013US20130183248 Method and kit for detection of autoimmune chronic urticaria
07/18/2013US20130183247 Fluorescent cyanine-polyamine derivatives as a diagnostic probe
07/18/2013US20130183236 Mmp-targeted therapeutic and/or diagnostic nanocarriers
07/18/2013US20130183234 Compositions Useful for Target, Detection, Imaging and Treatment, and Methods of Production and Use Thereof
07/18/2013CA2860843A1 Methods for preventing, treating or diagnosing disorders
07/17/2013EP2613791A2 Somatostatin receptor-based cancer therapy
07/17/2013EP2044961B1 Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
07/17/2013CN103209712A Colon screening by using magnetic particle imaging
07/17/2013CN103203031A Fe3O4/DOPA/(Gd/DTPA) nano material, and preparation method and application of material
07/17/2013CN103203030A Method for manufacturing KMnF<3> nuclear magnetic resonance imaging contrast agents
07/17/2013CN103203029A Fluid Path System For Dissolution And Transport Of A Hyperpolarized Material
07/17/2013CN103202808A Method for preparing multi-functional gossypol nano preparation by using one-pot method
07/17/2013CN102614532B Multifunctional tumor imaging agent, preparation method and application
07/17/2013CN102580121B Medical disinfection coupling agent
07/17/2013CN102558431B Preparation method of tumor developer folate--poly hydroxyethyl acrylate-diethylenetriamine pentaacetic acid
07/17/2013CN102441179B Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof
07/17/2013CN102220288B Mouse-addapted enterovirus EV71 strain 573 and use thereof
07/17/2013CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
07/17/2013CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance
07/17/2013CN101951963B MR imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used
07/16/2013US8488871 Three-dimensional ultrasonic inspection apparatus
07/16/2013US8486444 Nanobubbles useful as an ultrasonic contrast agent for the lymphatic system
07/16/2013US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF
07/16/2013US8486391 Cancer treatment kits using antibodies to aminophospholipids
07/16/2013US8486373 Intramolecularly-quenched near infrared fluorescent probes
07/16/2013US8486371 Quantitative two-photon flow cytometry
07/16/2013CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers
07/16/2013CA2512138C Kim-1 antagonists and use to modulate immune system
07/13/2013CA2800705A1 Fluid path system for dissolution and transport of a hyperpolarized material
07/11/2013WO2013019681A3 Selective delivery molecules and methods of use
07/11/2013US20130178726 Stabilized polymers for use with analyte sensors and methods for making and using them
07/11/2013US20130177647 Methods for manipulating satiety
07/11/2013US20130177607 Nanocell Drug Delivery System
07/11/2013US20130177503 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
07/11/2013US20130177502 Targeted, NIR Imaging Agents for Therapy Efficacy Monitoring, Deep Tissue Disease Demarcation and Deep Tissue Imaging
07/11/2013US20130177500 Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
07/11/2013DE102008047781B4 Peptide, die an durch Matrix-Metalloprotease 2 modifiziertes humanes Kollagen IV binden, pharmazeutische Zubereitung und deren Verwendung Peptides that bind to modified by matrix metalloprotease 2 human collagen IV, pharmaceutical preparation and the use thereof
07/10/2013EP2612683A2 Electro-physiologic contrast composition and method for manufacture.
07/10/2013EP2611822A2 Compositions for labeling nerves and methods of use
07/10/2013EP2611730A2 Iron oxide nanocapsules, method of manufacturing the same, and mri contrast agent using the same
07/10/2013CN103201211A Iron oxide nanocapsule, method of manufacturing the same, and mri contrast agent using the same
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 354